RxDoctor Payments Data

Jeanne Hungerpiller, MD

General Practice · Savannah, GANPI 1194885640

Payments from drug & device makers

$1,584in general payments, 2019–2025

Across 92 payments — averaging $17.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$430
  • Novo Nordisk$332
  • AstraZeneca$176
  • AbbVie$78
  • Boehringer Ingelheim$74
  • Esperion Therapeutics, Inc.$74
  • plus $419 from 13 others

What the payments were for

  • Food & beverage$1,584100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,584 in reported general payments places this provider in the 85th percentile of 2,542 general practice providers in Georgia.

See all general practice providers in Georgia

Medicare billing

Part B allowed, 2024
$24,774
Medicare patients
194
Services billed
341

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide47$87,370
OzempicSemaglutide48$54,650
JanuviaSitagliptin Phosphate57$47,197
JardianceEmpagliflozin27$35,216
XareltoRivaroxaban27$32,036
EliquisApixaban22$25,054
FarxigaDapagliflozin Propanediol15$16,445
LinzessLinaclotide13$6,917
TradjentaLinagliptin12$6,280
SynthroidLevothyroxine Sodium52$5,872
Levothyroxine Sodium292$3,171
Ezetimibe52$2,234
Atorvastatin Calcium295$2,185
Losartan Potassium218$2,171
Amlodipine Besylate398$2,165

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity$430$87,37047 claims
Novo NordiskOzempic$332$54,65048 claims
MerckJanuvia$11$47,19757 claims
Boehringer IngelheimJardiance, Tradjenta$74$41,49539 claims
PfizerEliquis$38$25,05422 claims
AstraZenecaFarxiga$176$16,44515 claims
AbbVieLinzess, Synthroid$78$12,78865 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,542 general practice providers in Georgia.

Other general practice in Savannah

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →